Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXW8RW
|
||||
Drug Name |
N-(2,4-difluorobenzyl)-N-((4-((5-cyanopyridin-2-yl)methyl)-4H-1,2,4-triazol-3-yl)methyl)quinoline-2-carboxamide
|
||||
Synonyms |
CHEMBL371423
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C27H19F2N7O
|
||||
Canonical SMILES |
Fc1ccc(CN(Cc2nncn2Cc3ccc(cn3)C#N)C(=O)c4ccc5ccccc5n4)c(F)c1
|
||||
InChI |
InChI=1S/C27H19F2N7O/c28-21-8-6-20(23(29)11-21)14-35(27(37)25-10-7-19-3-1-2-4-24(19)33-25)16-26-34-32-17-36(26)15-22-9-5-18(12-30)13-31-22/h1-11,13,17H,14-16H2
|
||||
InChIKey |
UZEOMOSDTQNLKZ-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.